Publication | Closed Access
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
139
Citations
32
References
2021
Year
NanomedicineNanotherapeuticsPolymer-drug ConjugateMedicineImmunologyTumor ImmunityPreferential Immune ResponseMinimal Doxorubicin-related ToxicityNano-drug DeliveryTumor TargetingImmunotherapyPharmacologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1